Correlation Between Immunome and AGE Old
Can any of the company-specific risk be diversified away by investing in both Immunome and AGE Old at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunome and AGE Old into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunome and AGE Old, you can compare the effects of market volatilities on Immunome and AGE Old and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunome with a short position of AGE Old. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunome and AGE Old.
Diversification Opportunities for Immunome and AGE Old
Very good diversification
The 3 months correlation between Immunome and AGE is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Immunome and AGE Old in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AGE Old and Immunome is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunome are associated (or correlated) with AGE Old. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AGE Old has no effect on the direction of Immunome i.e., Immunome and AGE Old go up and down completely randomly.
Pair Corralation between Immunome and AGE Old
If you would invest 74.00 in AGE Old on October 31, 2024 and sell it today you would earn a total of 0.00 from holding AGE Old or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 5.0% |
Values | Daily Returns |
Immunome vs. AGE Old
Performance |
Timeline |
Immunome |
AGE Old |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Immunome and AGE Old Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Immunome and AGE Old
The main advantage of trading using opposite Immunome and AGE Old positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunome position performs unexpectedly, AGE Old can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AGE Old will offset losses from the drop in AGE Old's long position.Immunome vs. Anebulo Pharmaceuticals | Immunome vs. Adagene | Immunome vs. Acrivon Therapeutics, Common | Immunome vs. AnaptysBio |
AGE Old vs. MAIA Biotechnology | AGE Old vs. Larimar Therapeutics | AGE Old vs. Lyra Therapeutics | AGE Old vs. Lineage Cell Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |